Intellia Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2014 The company specializes in developing innovative gene-editing therapies using CRISPR technology to address various genetic diseases Intellia has raised a total of $108 million in funding to support its research and development efforts With a strong focus on advancing its therapeutic pipeline, Intell...